Literature DB >> 20584031

Novel splice-site mutations and a large intragenic deletion in PLA2G6 associated with a severe and rapidly progressive form of infantile neuroaxonal dystrophy.

A Tonelli1, R Romaniello, R Grasso, A Cavallini, A Righini, N Bresolin, R Borgatti, M T Bassi.   

Abstract

Infantile neuroaxonal dystrophy, INAD, is a severe progressive psychomotor disorder with infantile onset and characterized by the presence of axonal spheroids throughout the central and peripheral nervous systems. A subset of INAD patients shows also brain iron accumulation which represents instead the distinctive feature of the idiopathic neurodegeneration with brain iron accumulation, NBIA. These diseases share the same causative gene, PLA2G6, encoding iPLA2-VIA, a calcium-independent phospholipase. Mutations that lead to a complete absence of protein are associated with a severe INAD profile, while compound heterozygous mutations with possibly a residual protein activity are instead associated with the less severe NBIA phenotype. Here we describe two INAD patients both with an unusually rapid disease progression and a peculiar neuroradiological presentation in one of them. Compound heterozygosity for a large intragenic deletion and a nonsense mutation was found in one of them while the other is carrying two novel splice-site mutations. Breakpoint-sequence analysis suggests a non-allelic-homologous-recombination (NAHR) event, probably underlying the rearrangement. These findings, while supporting the genotype-phenotype correlation already observed in INAD patients, provide the first sequence characterization of a genomic rearrangement in PLA2G6 gene, thus orienting the search for missing mutant alleles in PLA2G6 related diseases.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20584031     DOI: 10.1111/j.1399-0004.2010.01417.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  18 in total

Review 1.  Genetics of neurodegeneration with brain iron accumulation.

Authors:  Allison Gregory; Susan J Hayflick
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

Review 2.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

3.  Mutation screening of PLA2G6 in Japanese patients with early onset dystonia-parkinsonism.

Authors:  Chikara Yamashita; Manabu Funayama; Yuanzhe Li; Hiroyo Yoshino; Hitoshi Yamada; Yusuke Seino; Hiroyuki Tomiyama; Nobutaka Hattori
Journal:  J Neural Transm (Vienna)       Date:  2016-12-09       Impact factor: 3.575

4.  Monozygotic twins with infantile neuroaxonal dystrophy: A case report and literature review.

Authors:  Haifeng Li; Yan Zou; Xinhua Bao; Hui Wang; Jiangping Wang; Huiying Jin; Yuping Che; Xiaoyan Tang
Journal:  Exp Ther Med       Date:  2016-09-30       Impact factor: 2.447

5.  Loss of function variants in human PNPLA8 encoding calcium-independent phospholipase A2 γ recapitulate the mitochondriopathy of the homologous null mouse.

Authors:  Carol J Saunders; Sung Ho Moon; Xinping Liu; Isabelle Thiffault; Keith Coffman; Jean-Baptiste LePichon; Eugenio Taboada; Laurie D Smith; Emily G Farrow; Neil Miller; Margaret Gibson; Melanie Patterson; Stephen F Kingsmore; Richard W Gross
Journal:  Hum Mutat       Date:  2015-03       Impact factor: 4.878

6.  Fluoroketone inhibition of Ca(2+)-independent phospholipase A2 through binding pocket association defined by hydrogen/deuterium exchange and molecular dynamics.

Authors:  Yuan-Hao Hsu; Denis Bucher; Jian Cao; Sheng Li; Sheng-Wei Yang; George Kokotos; Virgil L Woods; J Andrew McCammon; Edward A Dennis
Journal:  J Am Chem Soc       Date:  2013-01-16       Impact factor: 15.419

7.  Genetic ablation of PLA2G6 in mice leads to cerebellar atrophy characterized by Purkinje cell loss and glial cell activation.

Authors:  Zhengshan Zhao; Jing Wang; Chunying Zhao; Weina Bi; Zhenyu Yue; Zhongmin Alex Ma
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

8.  Extensive aggregation of α-synuclein and tau in juvenile-onset neuroaxonal dystrophy: an autopsied individual with a novel mutation in the PLA2G6 gene-splicing site.

Authors:  Yuichi Riku; Takeshi Ikeuchi; Hiroyo Yoshino; Maya Mimuro; Kazuo Mano; Yoji Goto; Nobutaka Hattori; Gen Sobue; Mari Yoshida
Journal:  Acta Neuropathol Commun       Date:  2013-05-09       Impact factor: 7.801

9.  New findings in a global approach to dissect the whole phenotype of PLA2G6 gene mutations.

Authors:  Mustafa A Salih; Emeline Mundwiller; Arif O Khan; Abdulmajeed AlDrees; Salah A Elmalik; Hamdy H Hassan; Mohammed Al-Owain; Hisham M S Alkhalidi; Istvan Katona; Mohammad M Kabiraj; Roman Chrast; Amal Y Kentab; Hamad Alzaidan; Richard J Rodenburg; Thomas M Bosley; Joachim Weis; Michel Koenig; Giovanni Stevanin; Hamid Azzedine
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

10.  Genetic Analysis of PLA2G6 in 22 Indian Families with Infantile Neuroaxonal Dystrophy, Atypical Late-Onset Neuroaxonal Dystrophy and Dystonia Parkinsonism Complex.

Authors:  Saketh Kapoor; Mohd Hussain Shah; Nivedita Singh; Mohammad Iqbal Rather; Vishwanath Bhat; Sindhura Gopinath; Parayil Sankaran Bindu; Arun B Taly; Sanjib Sinha; Madhu Nagappa; Rose Dawn Bharath; Anita Mahadevan; Gayathri Narayanappa; Yasha T Chickabasaviah; Arun Kumar
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.